DK2567240T4 - Lipidomiske biomarkører til aterosklerose og kardiovaskulær sygdom - Google Patents
Lipidomiske biomarkører til aterosklerose og kardiovaskulær sygdom Download PDFInfo
- Publication number
- DK2567240T4 DK2567240T4 DK11719802.8T DK11719802T DK2567240T4 DK 2567240 T4 DK2567240 T4 DK 2567240T4 DK 11719802 T DK11719802 T DK 11719802T DK 2567240 T4 DK2567240 T4 DK 2567240T4
- Authority
- DK
- Denmark
- Prior art keywords
- biomarkears
- aterosclerosis
- lipidomic
- cardiovascular disease
- cardiovascular
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/04—Phospholipids, i.e. phosphoglycerides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33146310P | 2010-05-05 | 2010-05-05 | |
EP10162066.4A EP2385374B2 (en) | 2010-05-05 | 2010-05-05 | Lipidomic biomarkers for atherosclerosis and cardiovascular disease |
PCT/EP2011/057254 WO2011138419A1 (en) | 2010-05-05 | 2011-05-05 | Lipidomic biomarkers for atherosclerosis and cardiovascular disease |
Publications (2)
Publication Number | Publication Date |
---|---|
DK2567240T3 DK2567240T3 (da) | 2018-06-14 |
DK2567240T4 true DK2567240T4 (da) | 2021-05-31 |
Family
ID=42315849
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10162066.4T DK2385374T4 (da) | 2010-05-05 | 2010-05-05 | Lipidomik-biomarkører for atherosklerose og kardiovaskulær sygdom |
DK11719802.8T DK2567240T4 (da) | 2010-05-05 | 2011-05-05 | Lipidomiske biomarkører til aterosklerose og kardiovaskulær sygdom |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10162066.4T DK2385374T4 (da) | 2010-05-05 | 2010-05-05 | Lipidomik-biomarkører for atherosklerose og kardiovaskulær sygdom |
Country Status (9)
Country | Link |
---|---|
US (5) | US9046538B2 (da) |
EP (3) | EP2385374B2 (da) |
JP (1) | JP5871244B2 (da) |
CN (1) | CN102971633B (da) |
CA (1) | CA2798238C (da) |
DK (2) | DK2385374T4 (da) |
ES (2) | ES2455124T5 (da) |
NO (2) | NO2385374T3 (da) |
WO (1) | WO2011138419A1 (da) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9046540B2 (en) * | 2008-09-29 | 2015-06-02 | Plaxgen Inc. | Assay, composition and non-enzymatic mechanism of statin in modulating lipid metabolism |
ES2536712T3 (es) | 2009-11-27 | 2015-05-27 | Baker Idi Heart And Diabetes Institute Holdings Ltd | Biomarcadores lipidómicos para la enfermedad cardiaca estable e inestable |
AU2011209431B2 (en) * | 2010-01-29 | 2016-09-08 | Metanomics Gmbh | Means and methods for diagnosing heart failure in a subject |
EP2385374B2 (en) | 2010-05-05 | 2018-02-28 | Zora Biosciences OY | Lipidomic biomarkers for atherosclerosis and cardiovascular disease |
JP6262529B2 (ja) | 2010-06-20 | 2018-01-17 | ゾラ バイオサイエンシーズ オサケ ユキチュア | 冠状動脈疾患高リスク患者を認定するリピドームバイオマーカー |
US8765479B1 (en) * | 2011-03-13 | 2014-07-01 | Atherotech, Inc. | Methods for determining the risk of coronary heart disease and clinical manifestations of coronary heart disease |
US9541565B2 (en) | 2011-04-08 | 2017-01-10 | Zora Biosciences Oy | Biomarkers for sensitive detection of statin-induced muscle toxicity |
EP2592423A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment |
EP2592422A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment |
EP2642293A1 (en) | 2012-03-22 | 2013-09-25 | Nestec S.A. | 9-oxo-octadecadienoic acid (9-oxo-HODE)as as biomarker for healthy ageing |
EP2642295A1 (en) * | 2012-03-22 | 2013-09-25 | Nestec S.A. | 1-O-alkyl-2-acylglycerophosphocholine (PC-O) 40:1 as biomarker for healthy ageing |
EP2667197B1 (en) * | 2012-05-25 | 2015-09-16 | Zora Biosciences OY | Sensitive efficacy and specificity biomarkers for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition |
CN103149312B (zh) * | 2013-02-05 | 2015-02-04 | 东北农业大学 | 一种利用超高效液相色谱串联四级杆质谱分析婴儿乳粉中唾液酸的方法 |
EP2778686B1 (en) * | 2013-03-13 | 2016-07-27 | Academisch Ziekenhuis Leiden h.o.d.n. LUMC | Lipidomics of familial longevity |
WO2015071145A1 (en) * | 2013-11-14 | 2015-05-21 | Nestec S.A. | Lipid biomarkers of healthy ageing |
KR101660328B1 (ko) | 2014-01-14 | 2016-09-27 | 한국과학기술연구원 | 심혈관 질환 진단용 바이오 마커 |
WO2015156844A1 (en) | 2014-04-10 | 2015-10-15 | MEP Equine Solutions LLC | Method for the quantification of parasite eggs in feces |
US9347960B2 (en) | 2014-06-16 | 2016-05-24 | Zora Biosciences, Oy | Ceramides and their use in diagnosing CVD |
JP6814732B2 (ja) | 2014-09-11 | 2021-01-20 | リポサイエンス,インコーポレイテッド | Hdlおよび炎症性バイオマーカインタラクションパラメータを含むリスクパラメータを用いた心血管リスク評価 |
US10996231B2 (en) | 2014-12-16 | 2021-05-04 | Washington University | Ceramides for evaluating risk of cardiovascular disease |
WO2016112337A1 (en) | 2015-01-09 | 2016-07-14 | Global Genomics Group, LLC | Blood based biomarkers for diagnosing atherosclerotic coronary artery disease |
EP3121599A1 (en) * | 2015-07-23 | 2017-01-25 | Medizinische Hochschule Hannover | Analysis for atherosclerosis |
WO2017029401A1 (en) * | 2015-08-19 | 2017-02-23 | Metanomics Gmbh | Means and methods for diagnosing cardiac disease in a subject |
CN108027354B (zh) * | 2015-08-20 | 2021-01-08 | 深圳华大生命科学研究院 | 冠心病的生物标志物 |
EP3387446A2 (en) | 2015-12-07 | 2018-10-17 | Zora Biosciences OY | Use of ceramides and lpls in diagnosing cvd |
CN105486778B (zh) * | 2016-01-25 | 2017-11-03 | 齐炼文 | 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物 |
CN105445408B (zh) * | 2016-01-25 | 2018-06-12 | 齐炼文 | 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物 |
CN108872404A (zh) * | 2017-05-09 | 2018-11-23 | 中国科学院上海生命科学研究院 | 超长链饱和脂肪酸或其检测试剂在代谢综合征患病风险预测中的应用 |
CN107144624B (zh) * | 2017-05-15 | 2021-01-05 | 中国科学院生态环境研究中心 | 甄别二氧化硅颗粒来源的方法 |
JP2020523408A (ja) * | 2017-06-12 | 2020-08-06 | ヤンセン ファーマシューティカ エヌ.ベー. | 2型糖尿病の患者における心血管イベントの低減又は予防方法 |
CN109870536B (zh) * | 2017-12-05 | 2021-08-10 | 中国科学院大连化学物理研究所 | 一种基于液相色谱-质谱联用的高覆盖脂质组学分析方法 |
CN108037275A (zh) * | 2017-12-14 | 2018-05-15 | 北京豪思生物科技有限公司 | 一种用于评估冠状动脉疾病的试剂盒 |
WO2019119049A1 (en) * | 2017-12-20 | 2019-06-27 | Baker Heart and Diabetes Institute | Method of predicting drug therapeutic responder status and methods of treatment |
CN110433282B (zh) * | 2018-05-04 | 2023-03-14 | 上海交通大学医学院附属瑞金医院 | 胰高血糖素样肽-1在制备治疗钙化性主动脉瓣疾病药物方面的应用 |
KR20210100679A (ko) * | 2018-12-06 | 2021-08-17 | 조라 바이오사이언시즈 오와이 | 심혈관계 이벤트용 바이오마커 |
US20220214367A1 (en) * | 2019-04-15 | 2022-07-07 | Board Of Regents, The University Of Texas System | Calibration methods and compositions for biomolecule analysis |
US20220244279A1 (en) * | 2019-05-28 | 2022-08-04 | Ohio University | Assays and methods for screening for cardiovascular disease using ldl subclasses and endothelial nitric oxide/peroxynitrite balance |
CN112305122B (zh) * | 2020-10-30 | 2021-07-13 | 河北医科大学第二医院 | 代谢物标志物及其在疾病中的应用 |
CN112305119B (zh) * | 2020-10-30 | 2021-08-17 | 河北医科大学第二医院 | 动脉粥样硬化性脑梗死的生物标志物及其应用 |
CN112147344B (zh) * | 2020-10-30 | 2021-07-13 | 河北医科大学第二医院 | 动脉粥样硬化性脑梗死的代谢标志物及其在诊疗中的应用 |
CN112305124B (zh) * | 2020-10-30 | 2022-03-04 | 河北医科大学第二医院 | 一种生物标志物及其在疾病诊断中的应用 |
CN113782177A (zh) * | 2020-12-02 | 2021-12-10 | 北京市心肺血管疾病研究所 | 一种用于鉴别诊断冠心病患者斑块稳定性的数据处理装置、系统 |
CN112630330B (zh) * | 2020-12-08 | 2021-12-21 | 河北医科大学第二医院 | 小分子物质在脑梗死诊断中的应用 |
WO2022226191A1 (en) * | 2021-04-21 | 2022-10-27 | Albert Einstein College Of Medicine | Methods of stabilizing the neuronal proteome against collapse and protecting vascular cells |
CN113295793B (zh) * | 2021-05-20 | 2022-11-04 | 复旦大学附属中山医院 | 预测早期糖尿病以及糖尿病发生的生物标志物、其检测方法与应用 |
CN113960221B (zh) * | 2021-12-23 | 2022-02-25 | 中国中医科学院医学实验中心 | 基于粪便样本的胆汁酸全通路代谢轮廓的检测方法及其应用 |
CN113960222B (zh) * | 2021-12-23 | 2022-02-25 | 中国中医科学院医学实验中心 | 基于血清样本的胆汁酸全通路代谢轮廓的检测方法及其应用 |
CN114705873B (zh) * | 2022-06-06 | 2022-08-26 | 首都医科大学宣武医院 | 脂质作为颈动脉粥样硬化斑块诊断标志物的用途 |
CN115267214A (zh) * | 2022-08-10 | 2022-11-01 | 南方医科大学珠江医院 | 一种脂质代谢标志物、其筛选方法及其在颅内动脉瘤中的应用 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7590198A (en) * | 1997-06-10 | 1998-12-30 | Medlyte Diagnostics, Inc. | Methods for early detection of heart disease |
AU5610801A (en) | 2000-03-03 | 2001-09-12 | Gerd Schmitz | Method for the analysis of exogenic and endogenic cell activation based on measuring the aggregation of receptors |
US6664230B1 (en) | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
JP4062514B2 (ja) * | 2001-01-02 | 2008-03-19 | ザ・クリーブランド・クリニック・ファンデーション | ミエロペルオキシダーゼ、心臓血管疾患についての危険性指示因子 |
DK1353666T3 (da) | 2001-01-02 | 2013-10-14 | Cleveland Clinic Foundation | Myeloperoxidase, en risikoindikator for cardiovasculær sygdom |
EP1417629B1 (en) * | 2001-07-06 | 2008-02-20 | Lipomics Technologies, Inc. | Generating, viewing, interpreting, and utilizing a quantitative database of metabolites |
CN100347727C (zh) | 2002-06-28 | 2007-11-07 | Nxp股份有限公司 | 具有用于检测存储装置所存储信息产生变化的检测装置的数据载体 |
AU2003286726A1 (en) | 2002-10-25 | 2004-05-13 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
EP1615990A2 (en) * | 2003-03-28 | 2006-01-18 | Washington University in St. Louis | Multidimensional mass spectrometry of serum and cellular lipids directly from biologic extracts |
US20070244076A1 (en) * | 2003-10-08 | 2007-10-18 | Musc Foundation Research Development | Site and Rate Selective Prodrug Formulations of D609 with Antioxidant and Anticancer Activity |
EP1711197A4 (en) | 2003-12-23 | 2008-11-05 | Musc Found For Res Dev | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES OR DISORDERS |
EP1618876A1 (en) | 2004-07-19 | 2006-01-25 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Use of sphingolipids for prevention and treatment of atherosclerosis |
FI20041340A0 (fi) | 2004-10-15 | 2004-10-15 | Jurilab Ltd Oy | Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi |
US20060135497A1 (en) * | 2004-12-17 | 2006-06-22 | Ajay Gupta | Combination therapy for treating heart disease |
WO2006092025A1 (en) | 2005-03-03 | 2006-09-08 | Vital Health Sciences Pty Ltd | Compounds having lipid lowering properties |
EP1726962A1 (en) * | 2005-05-24 | 2006-11-29 | Leiden University Medical Center | Apolipoprotein E plasma levels for monitoring and reducing the risk of cardiovascular disease |
US7972802B2 (en) | 2005-10-31 | 2011-07-05 | University Of Washington | Lipoprotein-associated markers for cardiovascular disease |
US8137977B2 (en) * | 2006-04-24 | 2012-03-20 | Children's Hospital & Research Center At Oakland | Lipidomic approaches to determining drug response phenotypes in cardiovascular disease |
WO2007127192A2 (en) * | 2006-04-24 | 2007-11-08 | Duke University | Lipidomic approaches to determining drug response phenotypes in cardiovascular disease |
CN101522910A (zh) * | 2006-06-12 | 2009-09-02 | 佐拉生物科学有限公司 | 肌病的诊断方法 |
EP2029771A4 (en) | 2006-06-12 | 2010-08-04 | Zora Biosciences Oy | DIAGNOSTIC METHOD OF MYOPATHY |
JP4611941B2 (ja) | 2006-06-29 | 2011-01-12 | トヨタ自動車株式会社 | 内燃機関の排気還流装置 |
DE102006034153B4 (de) | 2006-07-24 | 2018-02-08 | Magna powertrain gmbh & co kg | Getriebe |
ES2527438T3 (es) * | 2006-08-08 | 2015-01-26 | Metabolon, Inc. | Marcadores de la hepatopatía grasa no alcohólica (NAFLD) y de la esteatohepatitis no alcohólica (NASH) y métodos de uso de los mismos |
EP2064544A1 (en) * | 2006-09-14 | 2009-06-03 | Zora Biosciences OY | Biofluid metabolite profiling as a tool for early prediction of autoimmunity and type 1 diabetes risk |
WO2008118413A2 (en) | 2007-03-26 | 2008-10-02 | Bg Medicine, Inc. | Methods for detecting coronary artery disease |
WO2008148857A1 (en) | 2007-06-07 | 2008-12-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for assessing the risk of a cardiovascular disease and for diagnosing dyslipidemia |
US8026099B2 (en) * | 2007-07-26 | 2011-09-27 | Washington University | Lipid profile as a biomarker for early detection of neurological disorders |
WO2009132082A2 (en) * | 2008-04-22 | 2009-10-29 | Medical College Of Georgia Research Institute, Inc. | Immunogenic compositions containing ceramide and methods of use thereof |
US10241093B2 (en) * | 2009-05-28 | 2019-03-26 | The Cleveland Clinic Foundation | Trimethylamine-containing compounds for diagnosis and prediction of disease |
ES2536712T3 (es) * | 2009-11-27 | 2015-05-27 | Baker Idi Heart And Diabetes Institute Holdings Ltd | Biomarcadores lipidómicos para la enfermedad cardiaca estable e inestable |
AU2011209431B2 (en) * | 2010-01-29 | 2016-09-08 | Metanomics Gmbh | Means and methods for diagnosing heart failure in a subject |
EP2385374B2 (en) | 2010-05-05 | 2018-02-28 | Zora Biosciences OY | Lipidomic biomarkers for atherosclerosis and cardiovascular disease |
-
2010
- 2010-05-05 EP EP10162066.4A patent/EP2385374B2/en active Active
- 2010-05-05 DK DK10162066.4T patent/DK2385374T4/da active
- 2010-05-05 ES ES10162066.4T patent/ES2455124T5/es active Active
- 2010-05-05 NO NO10162066A patent/NO2385374T3/no unknown
-
2011
- 2011-05-05 JP JP2013508512A patent/JP5871244B2/ja active Active
- 2011-05-05 CN CN201180032921.0A patent/CN102971633B/zh active Active
- 2011-05-05 CA CA2798238A patent/CA2798238C/en active Active
- 2011-05-05 DK DK11719802.8T patent/DK2567240T4/da active
- 2011-05-05 NO NO11719802A patent/NO2567240T3/no unknown
- 2011-05-05 US US13/695,766 patent/US9046538B2/en active Active
- 2011-05-05 EP EP11719802.8A patent/EP2567240B2/en active Active
- 2011-05-05 ES ES11719802T patent/ES2672054T5/es active Active
- 2011-05-05 EP EP18165052.4A patent/EP3399318B1/en active Active
- 2011-05-05 WO PCT/EP2011/057254 patent/WO2011138419A1/en active Application Filing
-
2015
- 2015-05-14 US US14/712,422 patent/US9459264B2/en active Active
-
2016
- 2016-08-25 US US15/246,851 patent/US9857386B2/en active Active
-
2017
- 2017-12-07 US US15/834,879 patent/US10551394B2/en active Active
-
2019
- 2019-12-16 US US16/715,801 patent/US20210003598A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2011138419A1 (en) | 2011-11-10 |
US9046538B2 (en) | 2015-06-02 |
US20180321266A1 (en) | 2018-11-08 |
US9857386B2 (en) | 2018-01-02 |
CA2798238A1 (en) | 2011-11-10 |
EP2385374B1 (en) | 2014-01-08 |
EP2567240A1 (en) | 2013-03-13 |
NO2567240T3 (da) | 2018-09-01 |
CN102971633A (zh) | 2013-03-13 |
US10551394B2 (en) | 2020-02-04 |
CN102971633B (zh) | 2016-08-10 |
DK2385374T3 (da) | 2014-03-17 |
US20130045217A1 (en) | 2013-02-21 |
US20150247873A1 (en) | 2015-09-03 |
EP2385374B2 (en) | 2018-02-28 |
ES2672054T5 (es) | 2021-11-22 |
US20160363601A1 (en) | 2016-12-15 |
EP3399318A1 (en) | 2018-11-07 |
ES2672054T3 (es) | 2018-06-12 |
JP2013527449A (ja) | 2013-06-27 |
DK2385374T4 (da) | 2018-04-30 |
EP2385374A1 (en) | 2011-11-09 |
DK2567240T3 (da) | 2018-06-14 |
EP3399318B1 (en) | 2020-03-04 |
JP5871244B2 (ja) | 2016-03-01 |
ES2455124T5 (es) | 2018-05-08 |
EP2567240B2 (en) | 2021-03-03 |
ES2455124T3 (es) | 2014-04-14 |
CA2798238C (en) | 2018-01-23 |
NO2385374T3 (da) | 2014-06-07 |
US9459264B2 (en) | 2016-10-04 |
US20210003598A1 (en) | 2021-01-07 |
EP2567240B1 (en) | 2018-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2567240T4 (da) | Lipidomiske biomarkører til aterosklerose og kardiovaskulær sygdom | |
SMT201600228B (it) | Sonda da focoemulsificazione bilanciata | |
DK2428450T3 (da) | Doseringsmetode og doseringsindretning | |
BR112012017441A2 (pt) | compostos e métodos | |
DK2649812T3 (da) | Høreapparat og en fremgangsmåde til at forbedre talegengivelse | |
DK2544719T3 (da) | Cd37-bindingsmolekyler og immunkonjugater deraf | |
BR112012027159A2 (pt) | estrutura e método | |
DK2552434T3 (da) | Peptider og anvendelse deraf | |
DK3572091T3 (da) | Modificerede relaxinpolypeptider og anvendelser deraf | |
NO345087B1 (no) | System og fremgangsmåte for forspenning av stigerør | |
DK2573550T3 (da) | Stofinspektionsindretning og inspektionsfremgangsmåde | |
DK2600715T3 (da) | Flydende ST-246-formuleringer og fremgangsmåder | |
DK2584921T3 (da) | Sondeernæringspakninger og fremgangsmåder til anvendelse deraf | |
BR112013009579A2 (pt) | método e comprimido | |
DE112011100722A5 (de) | Drehmomentmesswelle | |
DK2642992T3 (da) | Forbindelser og anvendelse deraf | |
DK2592938T3 (da) | Mejeriprodukt og fremgangsmåde | |
DK2704744T3 (da) | Komplementfaktor-b-analoger og anvendelser deraf | |
DOP2012000278A (es) | Tableta enterica | |
DE112011102851A5 (de) | Drehsteller | |
FIU20100025U0 (fi) | Jalustarakenne | |
DK2561225T3 (da) | Ståkonstruktion | |
FI9203U1 (fi) | Eriste-elementti | |
BR112013000298A2 (pt) | tablete | |
NO346499B1 (no) | Silanordning |